Retatrutide
Pre-approval Expanded Access of Retatrutide (LY3437943)
Eli Lilly · Phase n/r · Available · Enrollment n/r
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Registry arm not named | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.